These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 12612190)
1. Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy. Pietz J; Rupp A; Ebinger F; Rating D; Mayatepek E; Boesch C; Kreis R Pediatr Res; 2003 Apr; 53(4):654-62. PubMed ID: 12612190 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria. Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331 [TBL] [Abstract][Full Text] [Related]
3. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study. Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389 [TBL] [Abstract][Full Text] [Related]
4. The dynamics of brain concentrations of phenylalanine and its clinical significance in patients with phenylketonuria determined by in vivo 1H magnetic resonance spectroscopy. Pietz J; Kreis R; Boesch C; Penzien J; Rating D; Herschkowitz N Pediatr Res; 1995 Nov; 38(5):657-63. PubMed ID: 8552430 [TBL] [Abstract][Full Text] [Related]
5. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. Pietz J; Kreis R; Rupp A; Mayatepek E; Rating D; Boesch C; Bremer HJ J Clin Invest; 1999 Apr; 103(8):1169-78. PubMed ID: 10207169 [TBL] [Abstract][Full Text] [Related]
6. Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional Rijpma A; van der Graaf M; Meulenbroek O; Olde Rikkert MGM; Heerschap A Neuroimage Clin; 2018; 18():254-261. PubMed ID: 29876246 [TBL] [Abstract][Full Text] [Related]
7. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria. Möller HE; Weglage J; Bick U; Wiedermann D; Feldmann R; Ullrich K Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669 [TBL] [Abstract][Full Text] [Related]
8. Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria. Rupp A; Kreis R; Zschocke J; Slotboom J; Boesch C; Rating D; Pietz J J Cereb Blood Flow Metab; 2001 Mar; 21(3):276-84. PubMed ID: 11295882 [TBL] [Abstract][Full Text] [Related]
9. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria. Möller HE; Weglage J; Wiedermann D; Ullrich K J Cereb Blood Flow Metab; 1998 Nov; 18(11):1184-91. PubMed ID: 9809507 [TBL] [Abstract][Full Text] [Related]
10. Future role of large neutral amino acids in transport of phenylalanine into the brain. Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667 [TBL] [Abstract][Full Text] [Related]
11. Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies. Barbiroli B; Montagna P; Martinelli P; Lodi R; Iotti S; Cortelli P; Funicello R; Zaniol P J Cereb Blood Flow Metab; 1993 May; 13(3):469-74. PubMed ID: 8478405 [TBL] [Abstract][Full Text] [Related]
12. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease. Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496 [TBL] [Abstract][Full Text] [Related]
13. 1H MR chemical shift imaging detection of phenylalanine in patients suffering from phenylketonuria (PKU). Sijens PE; Oudkerk M; Reijngoud DJ; Leenders KL; de Valk HW; van Spronsen FJ Eur Radiol; 2004 Oct; 14(10):1895-900. PubMed ID: 15378255 [TBL] [Abstract][Full Text] [Related]
14. In vivo proton magnetic resonance spectroscopy in phenylketonuria. Möller HE; Ullrich K; Weglage J Eur J Pediatr; 2000 Oct; 159 Suppl 2():S121-5. PubMed ID: 11043158 [TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study. Leuzzi V; Tosetti M; Montanaro D; Carducci C; Artiola C; Carducci C; Antonozzi I; Burroni M; Carnevale F; Chiarotti F; Popolizio T; Giannatempo GM; D'Alesio V; Scarabino T J Inherit Metab Dis; 2007 Apr; 30(2):209-16. PubMed ID: 17245558 [TBL] [Abstract][Full Text] [Related]
16. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Pietz J; Kreis R; Schmidt H; Meyding-Lamadé UK; Rupp A; Boesch C Radiology; 1996 Nov; 201(2):413-20. PubMed ID: 8888233 [TBL] [Abstract][Full Text] [Related]
17. In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy. Novotny EJ; Avison MJ; Herschkowitz N; Petroff OA; Prichard JW; Seashore MR; Rothman DL Pediatr Res; 1995 Feb; 37(2):244-9. PubMed ID: 7731764 [TBL] [Abstract][Full Text] [Related]
18. Localised cerebral phosphorus-31 MR spectroscopy in man before and immediately after coronary bypass surgery with hypothermic cardiopulmonary bypass. Wilson JA; Taylor-Robinson SD; Bryant DJ; Taylor KM; Harris DN Metab Brain Dis; 1998 Sep; 13(3):191-200. PubMed ID: 9804364 [TBL] [Abstract][Full Text] [Related]
19. Deficit of brain and skeletal muscle bioenergetics and low brain magnesium in juvenile migraine: an in vivo 31P magnetic resonance spectroscopy interictal study. Lodi R; Montagna P; Soriani S; Iotti S; Arnaldi C; Cortelli P; Pierangeli G; Patuelli A; Zaniol P; Barbiroli B Pediatr Res; 1997 Dec; 42(6):866-71. PubMed ID: 9396571 [TBL] [Abstract][Full Text] [Related]
20. Bio-energetic impairment in human calf muscle in thyroid disorders: a 31P MRS study. Khushu S; Rana P; Sekhri T; Sripathy G; Tripathi RP Magn Reson Imaging; 2010 Jun; 28(5):683-9. PubMed ID: 20332062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]